Open Access 01-12-2018 | Review
Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
Published in: Diabetology & Metabolic Syndrome | Issue 1/2018
Login to get accessOpen Access 01-12-2018 | Review
Published in: Diabetology & Metabolic Syndrome | Issue 1/2018
Login to get access